Episodes
Looking for a specific episode? Search by guest name in the menu bar.
EP494: Six Tensions of Pharmaceutical Drug Pricing, With Sarah Emond
Listen On Your Favorite App I was out drinking martinis with Cora Opsahl, director of 32BJ Health Fund , and Cora said, "Look, most plan sponsors' biggest expense is health system spend, hospital spend." I know this is an unexpected start to an episode about pharmaceutical pricing and value featurin...
Bonus Add-on for EP494: Who Is ICER and What Is the Arms Race of Pharmaceutical Pricing That the Status Quo Has Created? With Sarah Emond
Listen On Your Favorite App Not gonna give much of an introduction here because this is a short bonus level set, but I did just wanna call everyone's attention to the "arms race" created by our status quo purchasing and selling of many things, pharmaceuticals included. For a full transcript of this ...
INBW43: Five Baskets of Thank Yous to Hand Out, Along With a Plug for Big Demand Curve Energy
Listen On Your Favorite App This episode is gonna drop on Thanksgiving, but whenever you are listening, I'd like to suggest taking this moment to be grateful. Everybody has someone to be thankful for: colleagues, our mentors, our cheerleaders, our support system, our community, our strategic allianc...
Take Two: EP240: A Direct Contracted and Actually High-Value Network That Elizabeth Mitchell From PBGH Talked About, With Olivia Ross
Listen On Your Favorite App This OG of directly contracted high-value networks or Centers of Excellence networks came up, name dropped and everything in the episode with Elizabeth Mitchell from PBGH , the Purchaser Business Group on Health, from two weeks ago. That was episode 491 . So, welcom...
EP493: Revelations Mainstream CEOs Are Having About the Healthcare Market Right Now—Also, Some Advice, With John Quinn
Listen On Your Favorite App Hello, all you great people trying to figure out how to do right by patients. Welcome to it. I was and am always extremely curious if any of what we talk about over here on Relentless Health Value has, in any way, percolated over to your average employer CEO—the ones who ...
EP492: The Solutions Show: How to Run a High-Quality Hospital at 143% of Medicare, With Sam Flanders, MD, and Shane Cerone
Listen On Your Favorite App Here's something that one of my guests today, Shane Cerone, says coming up here pretty quick. Shane Cerone and Dr. Sam Flanders are my return guests. Shane says, "We created a management model for our health system that was focused on surviving at 150% of Medicare. [Norma...
EP491: Incumbent TPAs and Consultants Getting Called to Jumbo Employer Client HQ to Answer Awkward Questions, With Elizabeth Mitchell
Listen On Your Favorite App Today, back on the pod, we have Elizabeth Mitchell, CEO of PBGH , the Purchaser Business Group on Health. Elizabeth Mitchell is talking about the why, as in why did PBGH embark on a big cost and quality safety transparency data demonstration project that they just finishe...
EP490: The Problem Show: 3 Problematic Hospital Myths, Including “There Is a Healthcare Market,” With Shane Cerone and Sam Flanders, MD
Listen On Your Favorite App Here’s a quote: “The reality is you can have razor-thin hospital margins if you are good at just spending all the money that is given to you.” Shane Cerone says this coming up and throw hot, right? Razor-thin hospital margins may be due to high costs or some problematic m...
EP489: MARGIN! Margin That Creates a Path to Mission at a Multispecialty Group, With Dan Greenleaf
Listen On Your Favorite App Ben Schwartz, MD, MBA, wrote an article recently, and yeah, he makes a really compelling point. Dr. Schwartz wrote, “Ultimately, the most successful care models are those that create value inherently. The goal isn’t simply cost arbitrage; it’s creating a sustainable syste...
EP489: Achieving Mission That Is a Path to Margin at a Multispecialty Practice, With Dan Greenleaf
Listen On Your Favorite App This show today is a continuation of our mission/margin series because I wanted to drag into my investigation here what clinical organizations are up to, especially ones that have brought in professional capital, as they say. Before I kick in here, let me just remind ever...